[1]
Girgenti V, Pelizzo G, Amoroso S, Rosone G, Di Mitri M, Milazzo M, Giordano S, Genuardi R, Calcaterra V. Emphysematous Pyelonephritis Following Ureterovesical Reimplantation for Congenital Obstructive Megaureter. Pediatric Case Report and Review of the Literature. Frontiers in pediatrics. 2019:7():2. doi: 10.3389/fped.2019.00002. Epub 2019 Jan 24
[PubMed PMID: 30733936]
Level 3 (low-level) evidence
[3]
Shortridge D, Duncan LR, Pfaller MA, Flamm RK. Activity of ceftolozane-tazobactam and comparators when tested against Gram-negative isolates collected from paediatric patients in the USA and Europe between 2012 and 2016 as part of a global surveillance programme. International journal of antimicrobial agents. 2019 May:53(5):637-643. doi: 10.1016/j.ijantimicag.2019.01.015. Epub 2019 Feb 1
[PubMed PMID: 30716448]
[4]
Shi H, Kang CI, Cho SY, Huh K, Chung DR, Peck KR. Follow-up blood cultures add little value in the management of bacteremic urinary tract infections. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2019 Apr:38(4):695-702. doi: 10.1007/s10096-019-03484-4. Epub 2019 Jan 28
[PubMed PMID: 30689071]
[5]
Gomila A, Carratalà J, Eliakim-Raz N, Shaw E, Wiegand I, Vallejo-Torres L, Gorostiza A, Vigo JM, Morris S, Stoddart M, Grier S, Vank C, Cuperus N, Van den Heuvel L, Vuong C, MacGowan A, Leibovici L, Addy I, Pujol M, COMBACTE MAGNET WP5 RESCUING Study Group and Study Sites. Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study. Infection and drug resistance. 2018:11():2571-2581. doi: 10.2147/IDR.S185753. Epub 2018 Dec 18
[PubMed PMID: 30588040]
Level 2 (mid-level) evidence
[6]
Esposito S, Rinaldi VE, Argentiero A, Farinelli E, Cofini M, D'Alonzo R, Mencacci A, Principi N. Approach to Neonates and Young Infants with Fever without a Source Who Are at Risk for Severe Bacterial Infection. Mediators of inflammation. 2018:2018():4869329. doi: 10.1155/2018/4869329. Epub 2018 Nov 26
[PubMed PMID: 30581369]
[7]
Cruz J, Figueiredo F, Matos AP, Duarte S, Guerra A, Ramalho M. Infectious and Inflammatory Diseases of the Urinary Tract: Role of MR Imaging. Magnetic resonance imaging clinics of North America. 2019 Feb:27(1):59-75. doi: 10.1016/j.mric.2018.09.001. Epub 2018 Oct 29
[PubMed PMID: 30466913]
[8]
Wagenlehner FME, Bjerklund Johansen TE, Cai T, Koves B, Kranz J, Pilatz A, Tandogdu Z. Epidemiology, definition and treatment of complicated urinary tract infections. Nature reviews. Urology. 2020 Oct:17(10):586-600. doi: 10.1038/s41585-020-0362-4. Epub 2020 Aug 25
[PubMed PMID: 32843751]
[9]
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature reviews. Microbiology. 2015 May:13(5):269-84. doi: 10.1038/nrmicro3432. Epub 2015 Apr 8
[PubMed PMID: 25853778]
[10]
Tandoğdu Z, Bartoletti R, Cai T, Çek M, Grabe M, Kulchavenya E, Köves B, Menon V, Naber K, Perepanova T, Tenke P, Wullt B, Johansen TE, Wagenlehner F. Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013. World journal of urology. 2016 Aug:34(8):1193-200. doi: 10.1007/s00345-015-1722-1. Epub 2015 Dec 11
[PubMed PMID: 26658886]
[11]
Zilberberg MD, Nathanson BH, Sulham K, Shorr AF. Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018. Open forum infectious diseases. 2022 Jan:9(1):ofab591. doi: 10.1093/ofid/ofab591. Epub 2022 Jan 10
[PubMed PMID: 35036460]
[12]
Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA, Healthcare Infection Control Practices Advisory Committee. Guideline for prevention of catheter-associated urinary tract infections 2009. Infection control and hospital epidemiology. 2010 Apr:31(4):319-26. doi: 10.1086/651091. Epub
[PubMed PMID: 20156062]
[13]
Tandogdu Z, Cek M, Wagenlehner F, Naber K, Tenke P, van Ostrum E, Johansen TB. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World journal of urology. 2014 Jun:32(3):791-801. doi: 10.1007/s00345-013-1154-8. Epub 2013 Aug 24
[PubMed PMID: 23979151]
[14]
Cek M, Tandoğdu Z, Wagenlehner F, Tenke P, Naber K, Bjerklund-Johansen TE. Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: results from the GPIU studies 2003-2010. World journal of urology. 2014 Dec:32(6):1587-94. doi: 10.1007/s00345-013-1218-9. Epub 2014 Jan 23
[PubMed PMID: 24452449]
Level 3 (low-level) evidence
[15]
Donnan JR, Grandy CA, Chibrikov E, Marra CA, Aubrey-Bassler K, Johnston K, Swab M, Hache J, Curnew D, Nguyen H, Gamble JM. Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis. BMJ open. 2019 Feb 1:9(1):e022577. doi: 10.1136/bmjopen-2018-022577. Epub 2019 Feb 1
[PubMed PMID: 30813108]
Level 2 (mid-level) evidence
[17]
Zilberberg MD, Nathanson BH, Sulham K, Shorr AF. Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016-2018. Journal of the American College of Emergency Physicians open. 2022 Apr:3(2):e12694. doi: 10.1002/emp2.12694. Epub 2022 Mar 17
[PubMed PMID: 35342898]
[18]
Tenke P, Köves B, Johansen TE. An update on prevention and treatment of catheter-associated urinary tract infections. Current opinion in infectious diseases. 2014 Feb:27(1):102-7. doi: 10.1097/QCO.0000000000000031. Epub
[PubMed PMID: 24345923]
Level 3 (low-level) evidence
[19]
Heyns CF. Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World journal of urology. 2012 Feb:30(1):77-83. doi: 10.1007/s00345-011-0725-9. Epub 2011 Jul 1
[PubMed PMID: 21720861]
[20]
Steward DK, Wood GL, Cohen RL, Smith JW, Mackowiak PA. Failure of the urinalysis and quantitative urine culture in diagnosing symptomatic urinary tract infections in patients with long-term urinary catheters. American journal of infection control. 1985 Aug:13(4):154-60
[PubMed PMID: 3850728]
[21]
Tenke P, Kovacs B, Jäckel M, Nagy E. The role of biofilm infection in urology. World journal of urology. 2006 Feb:24(1):13-20
[PubMed PMID: 16402262]
[22]
Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. The Journal of urology. 2000 Oct:164(4):1254-8
[PubMed PMID: 10992375]
[23]
Tenke P, Köves B, Nagy K, Hultgren SJ, Mendling W, Wullt B, Grabe M, Wagenlehner FM, Cek M, Pickard R, Botto H, Naber KG, Bjerklund Johansen TE. Update on biofilm infections in the urinary tract. World journal of urology. 2012 Feb:30(1):51-7. doi: 10.1007/s00345-011-0689-9. Epub 2011 May 18
[PubMed PMID: 21590469]
[24]
Brown MR, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? The Journal of antimicrobial chemotherapy. 1988 Dec:22(6):777-80
[PubMed PMID: 3072331]
[25]
Al Midani A, Elands S, Collier S, Harber M, Shendi AM. Impact of Urinary Tract Infections in Kidney Transplant Recipients: A 4-Year Single-Center Experience. Transplantation proceedings. 2018 Dec:50(10):3351-3355. doi: 10.1016/j.transproceed.2018.08.022. Epub 2018 Sep 7
[PubMed PMID: 30577206]
[28]
Nicolle LE. Urinary catheter-associated infections. Infectious disease clinics of North America. 2012 Mar:26(1):13-27. doi: 10.1016/j.idc.2011.09.009. Epub
[PubMed PMID: 22284373]
[29]
Limpawattana P, Phungoen P, Mitsungnern T, Laosuangkoon W, Tansangworn N. Atypical presentations of older adults at the emergency department and associated factors. Archives of gerontology and geriatrics. 2016 Jan-Feb:62():97-102. doi: 10.1016/j.archger.2015.08.016. Epub 2015 Aug 21
[PubMed PMID: 26323650]
[30]
MacRae V, Holland S, MacLeod R. Diagnosing, managing and preventing urinary tract infections in older people with dementia in hospital. Nursing older people. 2022 May 31:34(3):28-33. doi: 10.7748/nop.2022.e1392. Epub 2022 Apr 20
[PubMed PMID: 35441502]
[31]
El-Ghar MA, Farg H, Sharaf DE, El-Diasty T. CT and MRI in Urinary Tract Infections: A Spectrum of Different Imaging Findings. Medicina (Kaunas, Lithuania). 2021 Jan 1:57(1):. doi: 10.3390/medicina57010032. Epub 2021 Jan 1
[PubMed PMID: 33401464]
[32]
Tamburrini S, Lugarà M, Iannuzzi M, Cesaro E, De Simone F, Del Biondo D, Toto R, Iulia D, Marrone V, Faella P, Liguori C, Marano I. Pyonephrosis Ultrasound and Computed Tomography Features: A Pictorial Review. Diagnostics (Basel, Switzerland). 2021 Feb 17:11(2):. doi: 10.3390/diagnostics11020331. Epub 2021 Feb 17
[PubMed PMID: 33671431]
[33]
. NICE Guidance - Complicated urinary tract infections: ceftolozane/tazobactam: © NICE (2016) Complicated urinary tract infections: ceftolozane/tazobactam. BJU international. 2018 Jun:121(6):825-834. doi: 10.1111/bju.14364. Epub
[PubMed PMID: 29878700]
[34]
Lemoine L, Dupont C, Capron A, Cerf E, Yilmaz M, Verloop D, Blanckaert K, Senneville E, Alfandari S. Prospective evaluation of the management of urinary tract infections in 134 French nursing homes. Medecine et maladies infectieuses. 2018 Aug:48(5):359-364. doi: 10.1016/j.medmal.2018.04.387. Epub 2018 May 7
[PubMed PMID: 29747905]
[35]
Expert Panel on Pediatric Imaging:, Karmazyn BK, Alazraki AL, Anupindi SA, Dempsey ME, Dillman JR, Dorfman SR, Garber MD, Moore SG, Peters CA, Rice HE, Rigsby CK, Safdar NM, Simoneaux SF, Trout AT, Westra SJ, Wootton-Gorges SL, Coley BD. ACR Appropriateness Criteria(®) Urinary Tract Infection-Child. Journal of the American College of Radiology : JACR. 2017 May:14(5S):S362-S371. doi: 10.1016/j.jacr.2017.02.028. Epub
[PubMed PMID: 28473093]
[36]
Yasuda M. [Urogenital infections]. Nihon rinsho. Japanese journal of clinical medicine. 2017 Apr:75(4):558-566
[PubMed PMID: 30549857]
[37]
Bima P, Orlotti C, Smart OG, Morello F, Trunfio M, Brazzi L, Montrucchio G. Norepinephrine may improve survival of septic shock patients in a low-resource setting: a proof-of-concept study on feasibility and efficacy outside the Intensive Care Unit. Pathogens and global health. 2022 Sep:116(6):389-394. doi: 10.1080/20477724.2022.2038051. Epub 2022 Feb 9
[PubMed PMID: 35138990]
Level 2 (mid-level) evidence
[38]
Xu F, Zhong R, Shi S, Zeng Y, Tang Z. Early initiation of norepinephrine in patients with septic shock: A propensity score-based analysis. The American journal of emergency medicine. 2022 Apr:54():287-296. doi: 10.1016/j.ajem.2022.01.063. Epub 2022 Feb 3
[PubMed PMID: 35227959]
[39]
Shahrami B, Sharif M, Sefidani Forough A, Najmeddin F, Arabzadeh AA, Mojtahedzadeh M. Antibiotic therapy in sepsis: No next time for a second chance! Journal of clinical pharmacy and therapeutics. 2021 Aug:46(4):872-876. doi: 10.1111/jcpt.13403. Epub 2021 Mar 12
[PubMed PMID: 33710622]
[40]
Golan R, Cooper KL, Shah O. Management of Small, Non-obstructing Renal Stones in Adults With Recurrent Urinary Tract Infections. Reviews in urology. 2020:22(2):52-56
[PubMed PMID: 32760228]
[41]
Ward G, Jorden RC, Severance HW. Treatment of pyelonephritis in an observation unit. Annals of emergency medicine. 1991 Mar:20(3):258-61
[PubMed PMID: 1996820]
[42]
Choi JB, Min SK. Complicated urinary tract infection in patients with benign prostatic hyperplasia. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2021 Sep:27(9):1284-1287. doi: 10.1016/j.jiac.2021.06.006. Epub 2021 Jun 16
[PubMed PMID: 34144904]
[43]
Ten Doesschate T, Hendriks K, van Werkhoven CH, van der Hout EC, Platteel TN, Groenewegen IAM, Muller AE, Hoepelman AIM, Bonten MJM, Geerlings SE. Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2022 Feb:28(2):248-254. doi: 10.1016/j.cmi.2021.05.048. Epub 2021 Jun 8
[PubMed PMID: 34111584]
[44]
Muller AE, Verhaegh EM, Harbarth S, Mouton JW, Huttner A. Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2017 Jun:23(6):355-362. doi: 10.1016/j.cmi.2016.08.003. Epub 2016 Aug 17
[PubMed PMID: 27542332]
Level 1 (high-level) evidence
[46]
Lo TS, Hammer KD, Zegarra M, Cho WC. Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era. Expert review of anti-infective therapy. 2014 May:12(5):549-54. doi: 10.1586/14787210.2014.904202. Epub 2014 Apr 1
[PubMed PMID: 24689705]
[47]
Kevorkian CG, Merritt JL, Ilstrup DM. Methenamine mandelate with acidification: an effective urinary antiseptic in patients with neurogenic bladder. Mayo Clinic proceedings. 1984 Aug:59(8):523-9
[PubMed PMID: 6379319]
[48]
Kranz J, Lackner J, Künzel U, Wagenlehner F, Schmidt S. Original Article Phytotherapy in Adults With Recurrent Uncomplicated Cystitis. Deutsches Arzteblatt international. 2022 May 20:119(20):353-360. doi: 10.3238/arztebl.m2022.0104. Epub
[PubMed PMID: 35101170]
Level 1 (high-level) evidence
[49]
Jeitler M, Michalsen A, Schwiertz A, Kessler CS, Koppold-Liebscher D, Grasme J, Kandil FI, Steckhan N. Effects of a Supplement Containing a Cranberry Extract on Recurrent Urinary Tract Infections and Intestinal Microbiota: A Prospective, Uncontrolled Exploratory Study. Journal of integrative and complementary medicine. 2022 May:28(5):399-406. doi: 10.1089/jicm.2021.0300. Epub 2022 Mar 14
[PubMed PMID: 35285701]
[50]
Freire Gde C. Cranberries for preventing urinary tract infections. Sao Paulo medical journal = Revista paulista de medicina. 2013:131(5):363. doi: 10.1590/1516-3180.20131315T1. Epub
[PubMed PMID: 24310806]
[51]
Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. The Cochrane database of systematic reviews. 2015 Dec 23:2015(12):CD008772. doi: 10.1002/14651858.CD008772.pub2. Epub 2015 Dec 23
[PubMed PMID: 26695595]
Level 1 (high-level) evidence
[52]
Song F, Liu C, Zhang J, Lei Y, Hu Z. Antibacterial effect of fosfomycin tromethamine on the bacteria inside urinary infection stones. International urology and nephrology. 2020 Apr:52(4):645-654. doi: 10.1007/s11255-019-02358-0. Epub 2019 Dec 12
[PubMed PMID: 31832876]
[53]
De Lorenzis E, Alba AB, Cepeda M, Galan JA, Geavlete P, Giannakopoulos S, Saltirov I, Sarica K, Skolarikos A, Stavridis S, Yuruk E, Geavlete B, García-Carbajosa, Hristoforov S, Karagoz MA, Nassos N, Jurado GO, Paslanmaz F, Poza M, Saidi S, Tzelves L, Trinchieri A. Bacterial spectrum and antibiotic resistance of urinary tract infections in patients treated for upper urinary tract calculi: a multicenter analysis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2020 Oct:39(10):1971-1981. doi: 10.1007/s10096-020-03947-z. Epub 2020 Jun 16
[PubMed PMID: 32557326]
[54]
Kaye KS, Rice LB, Dane AL, Stus V, Sagan O, Fedosiuk E, Das AF, Skarinsky D, Eckburg PB, Ellis-Grosse EJ. Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 Nov 27:69(12):2045-2056. doi: 10.1093/cid/ciz181. Epub
[PubMed PMID: 30861061]
Level 1 (high-level) evidence
[55]
Derington CG, Benavides N, Delate T, Fish DN. Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting. Open forum infectious diseases. 2020 Feb:7(2):ofaa034. doi: 10.1093/ofid/ofaa034. Epub 2020 Jan 29
[PubMed PMID: 32123690]
[56]
Ziadeh T, Chebel R, Labaki C, Saliba G, Helou EE. Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review. Urologia. 2022 May:89(2):261-267. doi: 10.1177/03915603211049883. Epub 2021 Oct 6
[PubMed PMID: 34612750]
Level 1 (high-level) evidence
[57]
Abrams P, Hashim H, Tomson C, Macgowan A, Skews R, Warren K. The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction. Neurourology and urodynamics. 2017 Nov:36(8):2109-2116. doi: 10.1002/nau.23250. Epub 2017 May 15
[PubMed PMID: 28503891]
[58]
Moussa M, Chakra MA, Papatsoris AG, Dellis A, Dabboucy B, Fares Y. Bladder irrigation with povidone-iodine prevent recurrent urinary tract infections in neurogenic bladder patients on clean intermittent catheterization. Neurourology and urodynamics. 2021 Feb:40(2):672-679. doi: 10.1002/nau.24607. Epub 2021 Jan 21
[PubMed PMID: 33476092]
[59]
Miles BJ, Skoog S. Treatment of malakoplakia of bladder with intravesical neosporin irrigation. Urology. 1986 Jan:27(1):32-3
[PubMed PMID: 3001994]
[60]
Chernyak S, Salamon C. Intravesical Antibiotic Administration in the Treatment of Recurrent Urinary Tract Infections: Promising Results From a Case Series. Female pelvic medicine & reconstructive surgery. 2020 Feb:26(2):152-154. doi: 10.1097/SPV.0000000000000810. Epub
[PubMed PMID: 31990805]
Level 2 (mid-level) evidence
[61]
Chou A, Welch E, Hunter A, Trautner BW. Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review. Drugs. 2022 Mar:82(4):407-438. doi: 10.1007/s40265-022-01676-5. Epub 2022 Mar 14
[PubMed PMID: 35286622]
Level 3 (low-level) evidence
[62]
Tilahun M, Kassa Y, Gedefie A, Ashagire M. Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review. Infection and drug resistance. 2021:14():4363-4374. doi: 10.2147/IDR.S337611. Epub 2021 Oct 21
[PubMed PMID: 34707380]
[63]
Di Pietrantonio M, Brescini L, Candi J, Gianluca M, Pallotta F, Mazzanti S, Mantini P, Candelaresi B, Olivieri S, Ginevri F, Cesaretti G, Castelletti S, Cocci E, Polo RG, Cerutti E, Simonetti O, Cirioni O, Tavio M, Giacometti A, Barchiesi F. Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study. Antibiotics (Basel, Switzerland). 2022 Feb 28:11(3):. doi: 10.3390/antibiotics11030321. Epub 2022 Feb 28
[PubMed PMID: 35326784]
Level 2 (mid-level) evidence
[64]
Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, Gasink LB. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. The Lancet. Infectious diseases. 2016 Jun:16(6):661-673. doi: 10.1016/S1473-3099(16)30004-4. Epub 2016 Apr 20
[PubMed PMID: 27107460]
Level 1 (high-level) evidence
[65]
Wang C, Yang D, Wang Y, Ni W. Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence. Frontiers in pharmacology. 2022:13():896971. doi: 10.3389/fphar.2022.896971. Epub 2022 Apr 12
[PubMed PMID: 35496290]
Level 1 (high-level) evidence
[66]
Wang H, Palasik BN. Combating antimicrobial resistance with cefiderocol for complicated infections involving the urinary tract. Therapeutic advances in urology. 2022 Jan-Dec:14():17562872211065570. doi: 10.1177/17562872211065570. Epub 2022 Jan 31
[PubMed PMID: 35126672]
Level 3 (low-level) evidence
[67]
Kaye KS, Bhowmick T, Metallidis S, Bleasdale SC, Sagan OS, Stus V, Vazquez J, Zaitsev V, Bidair M, Chorvat E, Dragoescu PO, Fedosiuk E, Horcajada JP, Murta C, Sarychev Y, Stoev V, Morgan E, Fusaro K, Griffith D, Lomovskaya O, Alexander EL, Loutit J, Dudley MN, Giamarellos-Bourboulis EJ. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. JAMA. 2018 Feb 27:319(8):788-799. doi: 10.1001/jama.2018.0438. Epub
[PubMed PMID: 29486041]
Level 1 (high-level) evidence
[68]
Mouktaroudi M, Kotsaki A, Giamarellos-Bourboulis EJ. Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae. Expert review of anti-infective therapy. 2022 Jun:20(6):809-818. doi: 10.1080/14787210.2022.2030219. Epub 2022 Jan 26
[PubMed PMID: 35034551]
[69]
Clark JA, Burgess DS. Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance. Therapeutic advances in infectious disease. 2020 Jan-Dec:7():2049936120952604. doi: 10.1177/2049936120952604. Epub 2020 Sep 4
[PubMed PMID: 32953108]
Level 3 (low-level) evidence
[70]
Bassetti M, Giacobbe DR, Castaldo N, Russo A, Vena A. Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections. Current opinion in infectious diseases. 2021 Dec 1:34(6):748-755. doi: 10.1097/QCO.0000000000000789. Epub
[PubMed PMID: 34581282]
Level 3 (low-level) evidence
[71]
Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP, EPIC Study Group. Once-Daily Plazomicin for Complicated Urinary Tract Infections. The New England journal of medicine. 2019 Feb 21:380(8):729-740. doi: 10.1056/NEJMoa1801467. Epub
[PubMed PMID: 30786187]
[72]
Eckburg PB, Muir L, Critchley IA, Walpole S, Kwak H, Phelan AM, Moore G, Jain A, Keutzer T, Dane A, Melnick D, Talley AK. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection. The New England journal of medicine. 2022 Apr 7:386(14):1327-1338. doi: 10.1056/NEJMoa2105462. Epub
[PubMed PMID: 35388666]
[73]
Parida S, Mishra SK. Urinary tract infections in the critical care unit: A brief review. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2013 Nov:17(6):370-4. doi: 10.4103/0972-5229.123451. Epub
[PubMed PMID: 24501490]
[74]
Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE, Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010 Mar 1:50(5):625-63
[PubMed PMID: 20175247]
Level 1 (high-level) evidence
[75]
Podkovik S, Toor H, Gattupalli M, Kashyap S, Brazdzionis J, Patchana T, Bonda S, Wong S, Kang C, Mo K, Wacker MR, Miulli DE, Wang S. Prevalence of Catheter-Associated Urinary Tract Infections in Neurosurgical Intensive Care Patients - The Overdiagnosis of Urinary Tract Infections. Cureus. 2019 Aug 26:11(8):e5494. doi: 10.7759/cureus.5494. Epub 2019 Aug 26
[PubMed PMID: 31667030]
[76]
Neelakanta A, Sharma S, Kesani VP, Salim M, Pervaiz A, Aftab N, Mann T, Tashtoush N, Karino S, Dhar S, Kaye KS. Impact of changes in the NHSN catheter-associated urinary tract infection (CAUTI) surveillance criteria on the frequency and epidemiology of CAUTI in intensive care units (ICUs). Infection control and hospital epidemiology. 2015 Mar:36(3):346-9. doi: 10.1017/ice.2014.67. Epub
[PubMed PMID: 25695177]
[77]
Bardossy AC, Jayaprakash R, Alangaden AC, Starr P, Abreu-Lanfranco O, Reyes K, Zervos MJ, Alangaden GJ. Impact and Limitations of the 2015 National Health and Safety Network Case Definition on Catheter-Associated Urinary Tract Infection Rates. Infection control and hospital epidemiology. 2017 Feb:38(2):239-241. doi: 10.1017/ice.2016.278. Epub 2016 Nov 24
[PubMed PMID: 27881213]
Level 3 (low-level) evidence
[78]
Lachance CC, Grobelna A. Management of Patients with Long-Term Indwelling Urinary Catheters: A Review of Guidelines. 2019 May 14:():
[PubMed PMID: 31449368]
[79]
Warren JW. Catheter-associated urinary tract infections. International journal of antimicrobial agents. 2001 Apr:17(4):299-303
[PubMed PMID: 11295412]
[80]
Van Decker SG, Bosch N, Murphy J. Catheter-associated urinary tract infection reduction in critical care units: a bundled care model. BMJ open quality. 2021 Dec:10(4):. doi: 10.1136/bmjoq-2021-001534. Epub
[PubMed PMID: 34949580]
Level 2 (mid-level) evidence
[81]
Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public health reports (Washington, D.C. : 1974). 2007 Mar-Apr:122(2):160-6
[PubMed PMID: 17357358]
[82]
Shah PS, Cannon JP, Sullivan CL, Nemchausky B, Pachucki CT. Controlling antimicrobial use and decreasing microbiological laboratory tests for urinary tract infections in spinal-cord-injury patients with chronic indwelling catheters. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2005 Jan 1:62(1):74-7
[PubMed PMID: 15658076]
[83]
Warren JW. Catheter-associated urinary tract infections. Infectious disease clinics of North America. 1997 Sep:11(3):609-22
[PubMed PMID: 9378926]
[84]
Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clinic proceedings. 1999 Feb:74(2):131-6
[PubMed PMID: 10069349]
[85]
Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, Edwards JR, Sievert DM. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infection control and hospital epidemiology. 2016 Nov:37(11):1288-1301
[PubMed PMID: 27573805]
[86]
Washington EA. Instillation of 3% hydrogen peroxide or distilled vinegar in urethral catheter drainage bag to decrease catheter-associated bacteriuria. Biological research for nursing. 2001 Oct:3(2):78-87
[PubMed PMID: 11931525]
[87]
Nash MA. Best practice for patient self-cleaning of urinary drainage bags. Urologic nursing. 2003 Oct:23(5):334, 339
[PubMed PMID: 14621355]
[88]
Dailly S. Prevention of indwelling catheter-associated urinary tract infections. Nursing older people. 2011 Mar:23(2):14-9
[PubMed PMID: 21413662]
[89]
Chen YY, Chen CS, Chen IH, Lin CC. Comparison of the Incidence of Urinary Tract Infection by Replacement Time of the Urinary Drainage System. The journal of nursing research : JNR. 2021 May 28:29(4):e157. doi: 10.1097/JNR.0000000000000437. Epub 2021 May 28
[PubMed PMID: 34049325]
[90]
Moola S, Konno R. A systematic review of the management of short-term indwelling urethral catheters to prevent urinary tract infections. JBI library of systematic reviews. 2010:8(17):695-729
[PubMed PMID: 27820507]
Level 1 (high-level) evidence
[91]
Vallejo-Manzur F, Mireles-Cabodevila E, Varon J. Purple urine bag syndrome. The American journal of emergency medicine. 2005 Jul:23(4):521-4
[PubMed PMID: 16032624]
[92]
Benavides HA, Vargas Rodríguez LJ, Rozo Ortiz EJ. Purple urine bag syndrome. Medicina intensiva. 2022 Feb:46(2):119. doi: 10.1016/j.medine.2021.11.012. Epub 2021 Dec 2
[PubMed PMID: 34863669]
[93]
Shaeriya F, Al Remawy R, Makhdoom A, Alghamdi A, M Shaheen FA. Purple urine bag syndrome. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2021 Mar-Apr:32(2):530-531. doi: 10.4103/1319-2442.335466. Epub
[PubMed PMID: 35017348]
[94]
Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, Eckert LO, Geerlings SE, Köves B, Hooton TM, Juthani-Mehta M, Knight SL, Saint S, Schaeffer AJ, Trautner B, Wullt B, Siemieniuk R. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 May 2:68(10):e83-e110. doi: 10.1093/cid/ciy1121. Epub
[PubMed PMID: 30895288]
Level 1 (high-level) evidence
[95]
Skelton-Dudley F, Doan J, Suda K, Holmes SA, Evans C, Trautner B. Spinal Cord Injury Creates Unique Challenges in Diagnosis and Management of Catheter-Associated Urinary Tract Infection. Topics in spinal cord injury rehabilitation. 2019 Fall:25(4):331-339. doi: 10.1310/sci2504-331. Epub
[PubMed PMID: 31844385]
[96]
Skelton F, Grigoryan L, Holmes SA, Poon IO, Trautner B. Routine Urine Testing at the Spinal Cord Injury Annual Evaluation Leads to Unnecessary Antibiotic Use: A Pilot Study and Future Directions. Archives of physical medicine and rehabilitation. 2018 Feb:99(2):219-225. doi: 10.1016/j.apmr.2017.10.005. Epub 2017 Oct 26
[PubMed PMID: 29107038]
Level 3 (low-level) evidence
[97]
Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. The journal of spinal cord medicine. 2006:29(5):527-73
[PubMed PMID: 17274492]
Level 1 (high-level) evidence
[98]
Duffy LM, Cleary J, Ahern S, Kuskowski MA, West M, Wheeler L, Mortimer JA. Clean intermittent catheterization: safe, cost-effective bladder management for male residents of VA nursing homes. Journal of the American Geriatrics Society. 1995 Aug:43(8):865-70
[PubMed PMID: 7636093]
[99]
Chew AB, Suda KJ, Patel UC, Fitzpatrick MA, Ramanathan S, Burns SP, Evans CT. Long-term prescribing of nitrofurantoin for urinary tract infections (UTI) in veterans with spinal cord injury (SCI). The journal of spinal cord medicine. 2019 Jul:42(4):485-493. doi: 10.1080/10790268.2018.1488096. Epub 2018 Jul 9
[PubMed PMID: 29985783]
[100]
Phé V, Pakzad M, Haslam C, Gonzales G, Curtis C, Porter B, Chataway J, Panicker JN. Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis. Neurourology and urodynamics. 2017 Sep:36(7):1770-1775. doi: 10.1002/nau.23173. Epub 2016 Nov 4
[PubMed PMID: 27813195]
Level 2 (mid-level) evidence
[101]
Bonfill X, Rigau D, Esteban-Fuertes M, Barrera-Chacón JM, Jáuregui-Abrisqueta ML, Salvador S, Alemán-Sánchez CM, Borau A, Bea-Muñoz M, Hidalgo B, Andrade MJ, Espinosa JR, Martínez-Zapata MJ, ESCALE Study Group. Efficacy and safety of urinary catheters with silver alloy coating in patients with spinal cord injury: a multicentric pragmatic randomized controlled trial. The ESCALE trial. The spine journal : official journal of the North American Spine Society. 2017 Nov:17(11):1650-1657. doi: 10.1016/j.spinee.2017.05.025. Epub 2017 May 31
[PubMed PMID: 28578163]
Level 1 (high-level) evidence
[102]
Cardenas DD, Moore KN, Dannels-McClure A, Scelza WM, Graves DE, Brooks M, Busch AK. Intermittent catheterization with a hydrophilic-coated catheter delays urinary tract infections in acute spinal cord injury: a prospective, randomized, multicenter trial. PM & R : the journal of injury, function, and rehabilitation. 2011 May:3(5):408-17. doi: 10.1016/j.pmrj.2011.01.001. Epub
[PubMed PMID: 21570027]
Level 1 (high-level) evidence
[103]
Hess MJ, Hess PE, Sullivan MR, Nee M, Yalla SV. Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal cord. 2008 Sep:46(9):622-6. doi: 10.1038/sc.2008.25. Epub 2008 Apr 8
[PubMed PMID: 18392039]
[104]
Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. The Cochrane database of systematic reviews. 2012 Oct 17:10(10):CD001321. doi: 10.1002/14651858.CD001321.pub5. Epub 2012 Oct 17
[PubMed PMID: 23076891]
Level 1 (high-level) evidence
[105]
Trautner BW, Bhimani RD, Amspoker AB, Hysong SJ, Garza A, Kelly PA, Payne VL, Naik AD. Development and validation of an algorithm to recalibrate mental models and reduce diagnostic errors associated with catheter-associated bacteriuria. BMC medical informatics and decision making. 2013 Apr 15:13():48. doi: 10.1186/1472-6947-13-48. Epub 2013 Apr 15
[PubMed PMID: 23587259]
Level 1 (high-level) evidence
[106]
Trautner BW, Grigoryan L, Petersen NJ, Hysong S, Cadena J, Patterson JE, Naik AD. Effectiveness of an Antimicrobial Stewardship Approach for Urinary Catheter-Associated Asymptomatic Bacteriuria. JAMA internal medicine. 2015 Jul:175(7):1120-7. doi: 10.1001/jamainternmed.2015.1878. Epub
[PubMed PMID: 26010222]
[107]
Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. European journal of clinical investigation. 2008 Oct:38 Suppl 2():50-7. doi: 10.1111/j.1365-2362.2008.02009.x. Epub
[PubMed PMID: 18826482]
[108]
Moore A, Doull M, Grad R, Groulx S, Pottie K, Tonelli M, Courage S, Garcia AJ, Thombs BD, Canadian Task Force on Preventive Health Care. Recommendations on screening for asymptomatic bacteriuria in pregnancy. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2018 Jul 9:190(27):E823-E830. doi: 10.1503/cmaj.171325. Epub
[PubMed PMID: 29986858]
[109]
Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstetrics and gynecology. 1989 Apr:73(4):576-82
[PubMed PMID: 2927852]
Level 1 (high-level) evidence
[110]
Minassian C, Thomas SL, Williams DJ, Campbell O, Smeeth L. Acute maternal infection and risk of pre-eclampsia: a population-based case-control study. PloS one. 2013:8(9):e73047. doi: 10.1371/journal.pone.0073047. Epub 2013 Sep 3
[PubMed PMID: 24019891]
Level 2 (mid-level) evidence
[111]
Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. American journal of obstetrics and gynecology. 2014 Mar:210(3):219.e1-6. doi: 10.1016/j.ajog.2013.10.006. Epub 2013 Oct 5
[PubMed PMID: 24100227]
Level 2 (mid-level) evidence
[112]
Reeves DS. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: a review. Infection. 1992:20 Suppl 4():S313-6
[PubMed PMID: 1294525]
[113]
Vercaigne LM, Zhanel GG. Recommended treatment for urinary tract infection in pregnancy. The Annals of pharmacotherapy. 1994 Feb:28(2):248-51
[PubMed PMID: 8173146]
[114]
Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America, American Society of Nephrology, American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005 Mar 1:40(5):643-54
[PubMed PMID: 15714408]
[115]
Jolley JA, Wing DA. Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes. Drugs. 2010 Sep 10:70(13):1643-55. doi: 10.2165/11538050-000000000-00000. Epub
[PubMed PMID: 20731473]
[116]
Bidell MR, Lodise TP. Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings. Pharmacotherapy. 2018 Dec:38(12):1205-1215. doi: 10.1002/phar.2184. Epub 2018 Nov 9
[PubMed PMID: 30289995]
[117]
Neal DE Jr. Host defense mechanisms in urinary tract infections. The Urologic clinics of North America. 1999 Nov:26(4):677-86, vii
[PubMed PMID: 10584610]
[118]
Khan IH, Catto GR. Long-term complications of dialysis: infection. Kidney international. Supplement. 1993 Jun:41():S143-8
[PubMed PMID: 8320909]
[119]
Saitoh H, Nakamura K, Hida M, Satoh T. Urinary tract infection in oliguric patients with chronic renal failure. The Journal of urology. 1985 Jun:133(6):990-3
[PubMed PMID: 3999225]
[120]
Geerlings SE, Meiland R, Hoepelman AI. Pathogenesis of bacteriuria in women with diabetes mellitus. International journal of antimicrobial agents. 2002 Jun:19(6):539-45
[PubMed PMID: 12135845]
[121]
Fasolo LR, Rocha LM, Campbell S, Peixoto AJ. Diagnostic relevance of pyuria in dialysis patients. Kidney international. 2006 Dec:70(11):2035-8
[PubMed PMID: 16883321]
[122]
D'Agata EM, Mount DB, Thayer V, Schaffner W. Hospital-acquired infections among chronic hemodialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2000 Jun:35(6):1083-8
[PubMed PMID: 10845821]
[123]
Aloy B, Launay-Vacher V, Bleibtreu A, Bortolotti P, Faure E, Filali A, Gauzit R, Gilbert M, Lesprit P, Mahieu R, Meyssonnier V, Ogielska M, Romaru J, Salmon D, Alfandari S, Lemaignen A. Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice. Medecine et maladies infectieuses. 2020 Jun:50(4):323-331. doi: 10.1016/j.medmal.2019.06.010. Epub 2019 Jul 17
[PubMed PMID: 31326299]
[124]
Gilbert DN. Urinary tract infections in patients with chronic renal insufficiency. Clinical journal of the American Society of Nephrology : CJASN. 2006 Mar:1(2):327-31
[PubMed PMID: 17699224]
[125]
Scherberich JE, Fünfstück R, Naber KG. Urinary tract infections in patients with renal insufficiency and dialysis - epidemiology, pathogenesis, clinical symptoms, diagnosis and treatment. GMS infectious diseases. 2021:9():Doc07. doi: 10.3205/id000076. Epub 2021 Dec 21
[PubMed PMID: 35106269]
[126]
El Nekidy WS, Elrefaei H, St John TJL, Attallah NM, Kablaoui F, Nusair A, Piechowski-Jozwiak B, Phillips J, Ghazi IM. Ertapenem Neurotoxicity in Hemodialysis Patients-Safe and Effective Dosing Is Still Needed: A Retrospective Study and Literature Review. The Annals of pharmacotherapy. 2021 Jan:55(1):52-58. doi: 10.1177/1060028020938059. Epub 2020 Jul 3
[PubMed PMID: 32618479]
Level 2 (mid-level) evidence
[127]
Yamashita K, Ishiyama Y, Yoshino M, Tachibana H, Toki D, Konda R, Kondo T. Urinary Tract Infection in Hemodialysis-Dependent End-Stage Renal Disease Patients. Research and reports in urology. 2022:14():7-15. doi: 10.2147/RRU.S346020. Epub 2022 Jan 16
[PubMed PMID: 35079597]
[128]
Behzadi P, Urbán E, Matuz M, Benkő R, Gajdács M. The Role of Gram-Negative Bacteria in Urinary Tract Infections: Current Concepts and Therapeutic Options. Advances in experimental medicine and biology. 2021:1323():35-69. doi: 10.1007/5584_2020_566. Epub
[PubMed PMID: 32596751]
Level 3 (low-level) evidence
[129]
Sherwin E, King C, Hasen H, May S. Single-dose intravesical amikacin instillation for pyocystis in a patient with autonomic dysreflexia: A case report. The journal of spinal cord medicine. 2022 Nov:45(6):965-968. doi: 10.1080/10790268.2021.1922832. Epub 2021 May 13
[PubMed PMID: 33983103]
Level 3 (low-level) evidence
[130]
Ito K, Yamamoto T, Mori N. Pyocystis in an anuric patient undergoing chronic haemodialysis. Nephrology (Carlton, Vic.). 2017 May:22(5):420. doi: 10.1111/nep.12805. Epub
[PubMed PMID: 28378536]
[131]
Suzuki S, Sanda M, Kashiwagi Y. Pyocystis. The American journal of medicine. 2022 Feb:135(2):e49-e50. doi: 10.1016/j.amjmed.2021.08.032. Epub 2021 Sep 22
[PubMed PMID: 34560037]
[132]
Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Annals of transplantation. 2013 May 6:18():195-204. doi: 10.12659/AOT.883901. Epub 2013 May 6
[PubMed PMID: 23792521]
[133]
Simsek C, Karatas M, Tatar E, Tercan IC, Tasli Alkan F, Uslu A. Acute Allograft Pyelonephritis: Vague Symptoms, Indeterminate Laboratory Results, and the Necessity of Indication Biopsy. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 2022 Mar:20(Suppl 1):117-124. doi: 10.6002/ect.MESOT2021.P51. Epub
[PubMed PMID: 35384820]
[134]
Tandogdu Z, Cai T, Koves B, Wagenlehner F, Bjerklund-Johansen TE. Urinary Tract Infections in Immunocompromised Patients with Diabetes, Chronic Kidney Disease, and Kidney Transplant. European urology focus. 2016 Oct:2(4):394-399. doi: 10.1016/j.euf.2016.08.006. Epub 2016 Oct 5
[PubMed PMID: 28723471]
[135]
Krawczyk B, Wysocka M, Michalik M, Gołębiewska J. Urinary Tract Infections Caused by K. pneumoniae in Kidney Transplant Recipients - Epidemiology, Virulence and Antibiotic Resistance. Frontiers in cellular and infection microbiology. 2022:12():861374. doi: 10.3389/fcimb.2022.861374. Epub 2022 Apr 21
[PubMed PMID: 35531341]
[136]
Simon DM, Levin S. Infectious complications of solid organ transplantations. Infectious disease clinics of North America. 2001 Jun:15(2):521-49
[PubMed PMID: 11447708]
[137]
Lee JR, Bang H, Dadhania D, Hartono C, Aull MJ, Satlin M, August P, Suthanthiran M, Muthukumar T. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation. 2013 Oct 27:96(8):732-8. doi: 10.1097/TP.0b013e3182a04997. Epub
[PubMed PMID: 23917724]
[138]
Britt NS, Hagopian JC, Brennan DC, Pottebaum AA, Santos CAQ, Gharabagi A, Horwedel TA. Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2017 Oct 1:32(10):1758-1766. doi: 10.1093/ndt/gfx237. Epub
[PubMed PMID: 28967964]
[139]
Pellé G, Vimont S, Levy PP, Hertig A, Ouali N, Chassin C, Arlet G, Rondeau E, Vandewalle A. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2007 Apr:7(4):899-907
[PubMed PMID: 17286620]
[140]
Goh YSB, Deng Z, Cheong PSC, Raman L, Goh THA, Vathsala A, Tiong HY. Screening for asymptomatic bacteruria at one month after adult kidney transplantation: Clinical factors and implications. Clinical transplantation. 2017 May:31(5):. doi: 10.1111/ctr.12954. Epub 2017 Apr 9
[PubMed PMID: 28295630]
[141]
Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, Eckert LO, Geerlings SE, Köves B, Hooton TM, Juthani-Mehta M, Knight SL, Saint S, Schaeffer AJ, Trautner B, Wullt B, Siemieniuk R. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 May 2:68(10):1611-1615. doi: 10.1093/cid/ciz021. Epub
[PubMed PMID: 31506700]
Level 1 (high-level) evidence
[142]
Parasuraman R, Julian K, AST Infectious Diseases Community of Practice. Urinary tract infections in solid organ transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2013 Mar:13 Suppl 4():327-36. doi: 10.1111/ajt.12124. Epub
[PubMed PMID: 23465025]
[143]
Moradi M, Abbasi M, Moradi A, Boskabadi A, Jalali A. Effect of antibiotic therapy on asymptomatic bacteriuria in kidney transplant recipients. Urology journal. 2005 Winter:2(1):32-5
[PubMed PMID: 17629893]
[144]
Origüen J, López-Medrano F, Fernández-Ruiz M, Polanco N, Gutiérrez E, González E, Mérida E, Ruiz-Merlo T, Morales-Cartagena A, Pérez-Jacoiste Asín MA, García-Reyne A, San Juan R, Orellana MÁ, Andrés A, Aguado JM. Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2016 Oct:16(10):2943-2953. doi: 10.1111/ajt.13829. Epub 2016 May 23
[PubMed PMID: 27088545]
Level 1 (high-level) evidence
[145]
Pacaud M, Colas L, Kerleau C, Le Borgne F, Giral M, Brouard S, Dantal J. Impact of Late and Recurrent Acute Graft Pyelonephritis on Long-Term Kidney Graft Outcomes. Frontiers in immunology. 2022:13():824425. doi: 10.3389/fimmu.2022.824425. Epub 2022 Mar 2
[PubMed PMID: 35418982]
[146]
Powers HR, Hellinger WC, Cortese C, Elrefaei M, Khouzam S, Spiegel M, Li Z, Wadei HM. Histologic acute graft pyelonephritis after kidney transplantation: Incidence, clinical characteristics, risk factors, and association with graft loss. Transplant infectious disease : an official journal of the Transplantation Society. 2022 Apr:24(2):e13801. doi: 10.1111/tid.13801. Epub 2022 Feb 7
[PubMed PMID: 35080081]
[147]
Abbott KC, Swanson SJ, Richter ER, Bohen EM, Agodoa LY, Peters TG, Barbour G, Lipnick R, Cruess DF. Late urinary tract infection after renal transplantation in the United States. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 Aug:44(2):353-62
[PubMed PMID: 15264195]
[148]
Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clinical transplantation. 2005 Apr:19(2):230-5
[PubMed PMID: 15740560]
Level 2 (mid-level) evidence
[149]
Papasotiriou M, Savvidaki E, Kalliakmani P, Papachristou E, Marangos M, Fokaefs E, Maroulis I, Karavias D, Goumenos DS. Predisposing factors to the development of urinary tract infections in renal transplant recipients and the impact on the long-term graft function. Renal failure. 2011:33(4):405-10. doi: 10.3109/0886022X.2011.568137. Epub
[PubMed PMID: 21529269]
[150]
Muñoz P. Management of urinary tract infections and lymphocele in renal transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2001 Jul 1:33 Suppl 1():S53-7
[PubMed PMID: 11389523]
[151]
Horwedel TA, Bowman LJ, Saab G, Brennan DC. Benefits of sulfamethoxazole-trimethoprim prophylaxis on rates of sepsis after kidney transplant. Transplant infectious disease : an official journal of the Transplantation Society. 2014 Apr:16(2):261-9. doi: 10.1111/tid.12196. Epub 2014 Mar 13
[PubMed PMID: 24621104]
[152]
Arabi Z, Al Thiab K, Altheaby A, Aboalsamh G, Kashkoush S, Almarastani M, Shaheen MF, Altamimi A, O'hali W, Bin Saad K, Alnajjar L, Alhussein R, Almuhiteb R, Alqahtani B, Alotaibi R, Alqahtani M, Tawhari M. Urinary Tract Infections in the First 6 Months after Renal Transplantation. International journal of nephrology. 2021:2021():3033276. doi: 10.1155/2021/3033276. Epub 2021 Nov 15
[PubMed PMID: 34820141]
[153]
Hollyer I, Varias F, Ho B, Ison MG. Safety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: A single center, retrospective study. Transplant infectious disease : an official journal of the Transplantation Society. 2019 Jun:21(3):e13063. doi: 10.1111/tid.13063. Epub 2019 Mar 8
[PubMed PMID: 30776166]
Level 2 (mid-level) evidence
[154]
Quintero Cardona O, Hemmige VS, Puius YA. Methenamine hippurate may have particular benefit in preventing recurrent urinary tract infections in diabetic renal transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society. 2020 Apr:22(2):e13247. doi: 10.1111/tid.13247. Epub 2020 Jan 29
[PubMed PMID: 31957150]
[155]
Rosado-Canto R, Parra-Avila I, Tejeda-Maldonado J, Kauffman-Ortega C, Rodriguez-Covarrubias FT, Trujeque-Matos M, Cruz-Martínez R, Maravilla-Franco E, Criollo-Mora E, Arreola-Guerra JM, Morales-Buenrostro LE, Sifuentes-Osornio J. Perioperative fosfomycin disodium prophylaxis against urinary tract infection in renal transplant recipients: a randomized clinical trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2020 Nov 1:35(11):1996-2003. doi: 10.1093/ndt/gfz261. Epub
[PubMed PMID: 31883327]
Level 1 (high-level) evidence
[156]
Soriano F, Tauch A. Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2008 Jul:14(7):632-43. doi: 10.1111/j.1469-0691.2008.02023.x. Epub
[PubMed PMID: 18558935]
[157]
Santos JM, Batech M, Pelter MA, Deamer RL. Evaluation of the Risk of Nitrofurantoin Lung Injury and Its Efficacy in Diminished Kidney Function in Older Adults in a Large Integrated Healthcare System: A Matched Cohort Study. Journal of the American Geriatrics Society. 2016 Apr:64(4):798-805. doi: 10.1111/jgs.14072. Epub
[PubMed PMID: 27100576]
[158]
Singh N, Gandhi S, McArthur E, Moist L, Jain AK, Liu AR, Sood MM, Garg AX. Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2015 Jun 16:187(9):648-656. doi: 10.1503/cmaj.150067. Epub 2015 Apr 27
[PubMed PMID: 25918178]
[159]
Oplinger M, Andrews CO. Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL/min: looking for the evidence. The Annals of pharmacotherapy. 2013 Jan:47(1):106-11. doi: 10.1345/aph.1R352. Epub 2013 Jan 22
[PubMed PMID: 23341159]
[160]
Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infectious disease clinics of North America. 2003 Jun:17(2):243-59
[PubMed PMID: 12848469]
[161]
Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I, Stamm W, Israeli Urinary Tract Infection Group. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2002 May 1:34(9):1165-9
[PubMed PMID: 11941541]
[162]
Wesolek JL, Wu JY, Smalley CM, Wang L, Campbell MJ. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections. The American journal of emergency medicine. 2022 Jun:56():178-182. doi: 10.1016/j.ajem.2022.03.052. Epub 2022 Mar 31
[PubMed PMID: 35405469]
[163]
Jouret F, Lhommel R, Devuyst O, Annet L, Pirson Y, Hassoun Z, Kanaan N. Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2012 Oct:27(10):3746-51. doi: 10.1093/ndt/gfs352. Epub
[PubMed PMID: 23114901]
[164]
Pijl JP, Glaudemans AWJM, Slart RHJA, Kwee TC. (18)F-FDG PET/CT in Autosomal Dominant Polycystic Kidney Disease Patients with Suspected Cyst Infection. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2018 Nov:59(11):1734-1741. doi: 10.2967/jnumed.117.199448. Epub 2018 Apr 13
[PubMed PMID: 29653972]
[165]
Ronsin C, Bailly C, Le Turnier P, Ville S. Value of FDG-PET/CT in monitoring cyst infections in patients with autosomal dominant polycystic renal disease. Clinical kidney journal. 2021 Oct:14(10):2273-2275. doi: 10.1093/ckj/sfab077. Epub 2021 Apr 19
[PubMed PMID: 34603707]
[166]
Hasan SMM, Salh BS. Emphysematous cystitis as a potential marker of severe Crohn's disease. BMC gastroenterology. 2022 Apr 11:22(1):181. doi: 10.1186/s12876-022-02253-6. Epub 2022 Apr 11
[PubMed PMID: 35410166]
[167]
Grupper M, Kravtsov A, Potasman I. Emphysematous cystitis: illustrative case report and review of the literature. Medicine. 2007 Jan:86(1):47-53. doi: 10.1097/MD.0b013e3180307c3a. Epub
[PubMed PMID: 17220755]
Level 3 (low-level) evidence
[168]
Ranjan SK, Navriya SC, Kumar S, Mittal A, Bhirud DP. Emphysematous cystitis: A case report and literature review of 113 cases. Urology annals. 2021 Jul-Sep:13(3):312-315. doi: 10.4103/UA.UA_61_20. Epub 2021 Jun 23
[PubMed PMID: 34421272]
Level 3 (low-level) evidence
[169]
Olvera-Posada D, García-Mora A, Culebro-García C, Castillejos-Molina R, Sotomayor M, Feria-Bernal G, Rodríguez-Covarrubias F. [Prognostic factors in emphysematous pyelonephritis]. Actas urologicas espanolas. 2013 Apr:37(4):228-32. doi: 10.1016/j.acuro.2012.03.021. Epub 2012 Dec 20
[PubMed PMID: 23260183]
[170]
Desai R, Batura D. A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis. International urology and nephrology. 2022 Apr:54(4):717-736. doi: 10.1007/s11255-022-03131-6. Epub 2022 Feb 1
[PubMed PMID: 35103928]
Level 1 (high-level) evidence
[171]
Arrambide-Herrera JG, Robles-Torres JI, Ocaña-Munguía MA, Romero-Mata R, Gutiérrez-González A, Gómez-Guerra LS. Predictive factors for mortality and intensive care unit admission in patients with emphysematous pyelonephritis: 5-year experience in a tertiary care hospital. Actas urologicas espanolas. 2022 Mar:46(2):98-105. doi: 10.1016/j.acuroe.2021.01.010. Epub 2022 Feb 2
[PubMed PMID: 35120854]
[172]
Koch GE, Johnsen NV. The Diagnosis and Management of Life-threatening Urologic Infections. Urology. 2021 Oct:156():6-15. doi: 10.1016/j.urology.2021.05.011. Epub 2021 May 17
[PubMed PMID: 34015395]
[173]
Anıl H, Şener NC, Karamık K, Erol İ, Vuruşkan E, Erçil H, Gürbüz ZG. Comparison of Percutaneous Nephrostomy and Ureteral DJ Stent in Patients with Obstructive Pyelonephritis: A Retrospective Cohort Study. Journal of investigative surgery : the official journal of the Academy of Surgical Research. 2022 Jul:35(7):1445-1450. doi: 10.1080/08941939.2022.2062496. Epub 2022 Apr 12
[PubMed PMID: 35414347]
Level 2 (mid-level) evidence
[174]
Abi Tayeh G, Safa A, Sarkis J, Alkassis M, Khalil N, Nemr E, El Helou E. Determinants of pyelonephritis onset in patients with obstructive urolithiasis. Urologia. 2022 Feb:89(1):100-103. doi: 10.1177/03915603211035244. Epub 2021 Aug 2
[PubMed PMID: 34338097]
[176]
Chang CW, Huang CN. Pyonephrosis drained by double-J catheter. Clinical case reports. 2020 Dec:8(12):3586-3587. doi: 10.1002/ccr3.3204. Epub 2020 Sep 2
[PubMed PMID: 33363990]
Level 3 (low-level) evidence
[177]
Itami Y, Miyake M, Owari T, Iwamoto T, Gotoh D, Momose H, Fujimoto K, Hirao S. Optimal timing of ureteroscopic lithotripsy after the initial drainage treatment and risk factors for postoperative febrile urinary tract infection in patients with obstructive pyelonephritis: a retrospective study. BMC urology. 2021 Jan 15:21(1):10. doi: 10.1186/s12894-020-00754-8. Epub 2021 Jan 15
[PubMed PMID: 33451332]
Level 2 (mid-level) evidence
[178]
Cui C, Jiang J, Chen W, Cui LG, Wang JR. [Xanthogranulonatous pyelonephritis: report of 5 cases]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences. 2018 Aug 18:50(4):743-746
[PubMed PMID: 30122783]
Level 3 (low-level) evidence
[179]
Iskandar SS, Prahlow JA, White WL. Lipid-laden foamy macrophages in renal cell carcinoma. Potential frozen section diagnostic pitfall. Pathology, research and practice. 1993 Jun:189(5):549-52
[PubMed PMID: 8378177]
[181]
Werneburg GT. Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects. Research and reports in urology. 2022:14():109-133. doi: 10.2147/RRU.S273663. Epub 2022 Apr 4
[PubMed PMID: 35402319]
[182]
Rigvava S, Kusradze I, Tchgkonia I, Karumidze N, Dvalidze T, Goderdzishvili M. Novel lytic bacteriophage vB_GEC_EfS_9 against Enterococcus faecium. Virus research. 2022 Jan 2:307():198599. doi: 10.1016/j.virusres.2021.198599. Epub 2021 Oct 12
[PubMed PMID: 34648886]
[183]
Slobodníková L, Markusková B, Kajsík M, Andrezál M, Straka M, Liptáková A, Drahovská H. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic Escherichia coli. Viruses. 2021 Jul 12:13(7):. doi: 10.3390/v13071348. Epub 2021 Jul 12
[PubMed PMID: 34372554]
[184]
Chegini Z, Khoshbayan A, Vesal S, Moradabadi A, Hashemi A, Shariati A. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review. Annals of clinical microbiology and antimicrobials. 2021 Apr 26:20(1):30. doi: 10.1186/s12941-021-00433-y. Epub 2021 Apr 26
[PubMed PMID: 33902597]
Level 3 (low-level) evidence
[185]
Dasgupta M, Brymer C, Elsayed S. Treatment of asymptomatic UTI in older delirious medical in-patients: A prospective cohort study. Archives of gerontology and geriatrics. 2017 Sep:72():127-134. doi: 10.1016/j.archger.2017.05.010. Epub 2017 May 31
[PubMed PMID: 28624753]
[186]
Sundvall PD, Ulleryd P, Gunnarsson RK. Urine culture doubtful in determining etiology of diffuse symptoms among elderly individuals: a cross-sectional study of 32 nursing homes. BMC family practice. 2011 May 19:12():36. doi: 10.1186/1471-2296-12-36. Epub 2011 May 19
[PubMed PMID: 21592413]
Level 2 (mid-level) evidence
[187]
Bonine NG, Berger A, Altincatal A, Wang R, Bhagnani T, Gillard P, Lodise T. Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections. The American journal of the medical sciences. 2019 Feb:357(2):103-110. doi: 10.1016/j.amjms.2018.11.009. Epub 2018 Nov 22
[PubMed PMID: 30665490]
[188]
Karve S, Ryan K, Peeters P, Baelen E, Rojas-Farreras S, Potter D, Rodríguez-Baño J. The impact of initial antibiotic treatment failure: Real-world insights in patients with complicated urinary tract infection. The Journal of infection. 2018 Feb:76(2):121-131. doi: 10.1016/j.jinf.2017.11.001. Epub 2017 Nov 8
[PubMed PMID: 29128389]